{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T01:23:05Z","timestamp":1769390585919,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.neulet.2011.02.063","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T19:14:51Z","timestamp":1299525291000},"page":"86-88","source":"Crossref","is-referenced-by-count":19,"title":["Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome"],"prefix":"10.1016","volume":"494","author":[{"given":"Chihiro","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2011.02.063_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2009.08.032","article-title":"Neurological autoimmunity targeting aquaporin-4","volume":"168","author":"Hinson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2011.02.063_bib0010","first-page":"395","article-title":"Analysis of reference values of serum S100B concentrations of Japanese adults","volume":"53","author":"Ikeda","year":"2005","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.neulet.2011.02.063_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","article-title":"Serum S-100beta as a possible marker of blood\u2013brain barrier disruption","volume":"940","author":"Kapural","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.02.063_bib0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2011.02.063_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-5751-3-4","article-title":"Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a","volume":"3","author":"Lim","year":"2004","journal-title":"J. Negat. Results Biomed."},{"key":"10.1016\/j.neulet.2011.02.063_bib0030","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/1352458509104595","article-title":"Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese","volume":"15","author":"Matsushita","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2011.02.063_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2011.02.063_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1997.tb00256.x","article-title":"Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein","volume":"96","author":"Missler","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neulet.2011.02.063_bib0045","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2011.02.063_bib0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2011.02.063_bib0055","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2011.02.063_bib0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/jnr.21211","article-title":"S100B in neuropathologic states: the CRP of the brain?","volume":"85","author":"Sen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2011.02.063_bib0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2011.02.063_bib0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/1352458507076976","article-title":"Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions","volume":"13","author":"Tanaka","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2011.02.063_bib0075","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica\u2013IgG astrocyte interactions on blood\u2013brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2011.02.063_bib0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2011.02.063_bib0085","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011002540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011002540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T06:57:50Z","timestamp":1543906670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394011002540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0304394011002540"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2011.02.063","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}